OS Therapies IncorporatedOSTXNYSE
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+63.5%
5Y CAGR+574.1%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+63.5%/yr
Annual compound
5Y CAGR
+574.1%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
13918.9x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $19.44M | +185.5% |
| 2024 | $6.81M | +56.8% |
| 2023 | $4.34M | -2.3% |
| 2022 | $4.45M | +20.9% |
| 2021 | $3.68M | +263157.9% |
| 2020 | $1397.00 | - |